本页面由Tiger Trade Technology Pte. Ltd.提供服务

Autolus Therapeutics PLC

1.40
+0.02001.45%
盘后1.400.00000.00%16:54 EST
成交量:92.66万
成交额:130.94万
市值:3.73亿
市盈率:-1.66
高:1.44
开:1.39
低:1.39
收:1.38
52周最高:2.70
52周最低:1.11
股本:2.66亿
流通股本:1.19亿
量比:0.91
换手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-0.8446
每股收益(LYR):-0.8648
净资产收益率:-60.56%
总资产收益率:-22.99%
市净率:1.40
市盈率(LYR):-1.62

数据加载中...

公司资料

公司名字:
Autolus Therapeutics PLC
交易所:
NASDAQ
成立时间:
2014
员工人数:
649
公司地址:
The Mediaworks,191 Wood Lane,White City,London,Greater London,United Kingdom
邮编:
W12 7FP
传真:
- -
简介:
Autolus Therapeutics plc于2018年2月2日在英格兰和威尔士注册成立。该公司是一家生物制药公司,开发用于治疗癌症和自身免疫性疾病的下一代程序性T细胞疗法。使用该公司广泛的专有和模块化T细胞编程技术套件,该公司正在设计精确靶向、受控和高活性的T细胞疗法,这些疗法旨在更好地识别目标细胞、打破其防御机制并攻击和消除这些细胞。

董事

名称
职位
Christian Itin
Chief Executive Officer and Director
Michael Bonney
Chairman of the Board
Cynthia Butitta
Director
Elisabeth Leiderman
Director
John Berriman
Director
Joseph Anderson
Director
Linda Bain
Director
Martin Murphy
Director
Ravi Rao
Director
Robert Azelby
Director
Robert Iannone
Director
Ryan Richardson
Director
William Young
Director

股东

名称
职位
Christian Itin
Chief Executive Officer and Director
Christopher Vann
Senior Vice President, Chief Operating Officer
Alex Driggs
Senior Vice President, Legal Affairs and General Counsel
Alexander Swan
Senior Vice President, Chief Human Resources Officer
Brent Rice
Senior Vice President, Chief Commercial Officer
Christopher Williams
Senior Vice President, Chief Business Development Officer
David Brochu
Senior Vice President, Chief Technical Officer
Martin Pule
Senior Vice President, Founder, Chief Scientific Officer
Matthias Will
Senior Vice President, Chief Development Officer
Miranda Neville
Senior Vice President, Chief Project Officer
Robert Dolski
Senior Vice President, Chief Financial Officer
Patrick McIlvenny
Principal Accounting Officer